Clarke R - Search Results

1

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.

Riggins RB, Bouton AH, Liu MC, Clarke R. Riggins RB, et al. Among authors: clarke r. Vitam Horm. 2005;71:201-37. doi: 10.1016/S0083-6729(05)71007-4. Vitam Horm. 2005. PMID: 16112269 Review.

2

Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.

Clarke R, Currier S, Kaplan O, Lovelace E, Boulay V, Gottesman MM, Dickson RB. Clarke R, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1506-12. doi: 10.1093/jnci/84.19.1506. J Natl Cancer Inst. 1992. PMID: 1359153

3

The process of malignant progression in human breast cancer.

Clarke R, Dickson RB, Brünner N. Clarke R, et al. Ann Oncol. 1990 Nov;1(6):401-7. doi: 10.1093/oxfordjournals.annonc.a057790. Ann Oncol. 1990. PMID: 2083184 Free article. Review.

4

Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors.

Brünner N, Zugmaier G, Bano M, Ennis BW, Clarke R, Cullen KJ, Kern FG, Dickson RB, Lippman ME. Brünner N, et al. Among authors: clarke r. Cancer Cells. 1989 Nov;1(3):81-6. Cancer Cells. 1989. PMID: 2701652 Review.

5

Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

Clarke R, Skaar T, Baumann K, Leonessa F, James M, Lippman J, Thompson EW, Freter C, Brunner N. Clarke R, et al. Breast Cancer Res Treat. 1994;31(2-3):237-48. doi: 10.1007/BF00666157. Breast Cancer Res Treat. 1994. PMID: 7881102 Review.

6

MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

Brünner N, Frandsen TL, Holst-Hansen C, Bei M, Thompson EW, Wakeling AE, Lippman ME, Clarke R. Brünner N, et al. Among authors: clarke r. Cancer Res. 1993 Jul 15;53(14):3229-32. Cancer Res. 1993. PMID: 8324732

7

Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brünner N. Clarke R, et al. Breast Cancer Res Treat. 1993;24(3):227-39. doi: 10.1007/BF01833263. Breast Cancer Res Treat. 1993. PMID: 8435478 Review.

8

MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

Leonessa F, Green D, Licht T, Wright A, Wingate-Legette K, Lippman J, Gottesman MM, Clarke R. Leonessa F, et al. Among authors: clarke r. Br J Cancer. 1996 Jan;73(2):154-61. doi: 10.1038/bjc.1996.29. Br J Cancer. 1996. PMID: 8546900 Free PMC article.

9

Estrogens, phytoestrogens, and breast cancer.

Clarke R, Hilakivi-Clarke L, Cho E, James MR, Leonessa F. Clarke R, et al. Adv Exp Med Biol. 1996;401:63-85. doi: 10.1007/978-1-4613-0399-2_6. Adv Exp Med Biol. 1996. PMID: 8886127 Review. No abstract available.

10

Cellular and molecular pharmacology of antiestrogen action and resistance.

Clarke R, Leonessa F, Welch JN, Skaar TC. Clarke R, et al. Pharmacol Rev. 2001 Mar;53(1):25-71. Pharmacol Rev. 2001. PMID: 11171938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,225 results

Search Page

Filters